20 - 21 Feb, 2023
Training on Management of Personnel in GMP Environment

An interactive two-day training programme was held on the topic of Management of Personnel in GMP Environment, as part of Good Manufacturing Practice (GMP) for the Georgian Biopharmaceutical Cluster. The training proceeded with high level of attendance and engagement from the attendants.

Successful implementation of the quality standard requires a human resource management system that ensures continuous supervision of personnel to minimize risks and maintain hygiene, quality and safety of processes. The training on Management of Personnel was delivered as a continuation of the series of trainings on Good Manufacturing Practice (GMP), ongoing since May 2022.

This time the focus of the trainings were on the management of quality assurance personnel, which is crucial for the overall success of GMP implementation in practice. Quality assurance personnel play a key role in the daily execution of quality and safety procedures.

The training programme was conducted by highly qualified international and national experts and with a high level of engagement from 26 representatives of pharmaceutical companies. Among them, 69% were female. The trainings made it possible for the member companies to come closer to becoming GMP certified. Thanks to the trainings and coaching, we successfully passed the inspection and became GDP compliant” - Mariam Kveselava, Quality assurance responsible person at Neopharm.

The training programme was organized under the EU4Georgia project on Innovative Action for Private Sector Competitiveness in Georgia. The programme is funded by the European Union (EU) with a budget of Euro 6 million and implemented by four UN agencies – the United Nations Development Programme (UNDP), the Food and Agriculture Organization of the United Nations (FAO), the United Nations Industrial Development Organisation (UNIDO) and the International Organization for Migration (IOM).

This website has been produced with the assistance of the European Union (EU) and the United Nations Industrial Development Organization (UNIDO). Its content is the sole responsibility of The Georgian Biopharmaceutical Cluster and do not necessarily reflect the views of the European Union and the United Nations Industrial Development Organization